TargetMol

Tazomeline

Product Code:
 
TAR-T68153
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T68153-1mg1mg£157.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T68153-5mg5mg£279.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T68153-10mg10mg£384.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T68153-25mg25mg£595.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T68153-50mg50mg£816.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T68153-100mg100mg£1,083.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T68153-500mg500mg£2,103.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Tazomeline is a muscarinic M1 receptor agonist with neuroprotective activity.
CAS:
131987-54-7
Molecular Weight:
277.79
Pathway:
Neuroscience
Purity:
1
SMILES:
Cl.O=C(OC1CC(N(O)C(C)(C)C1)(C)C)C2CC2
Target:
AChR

References

Ward JS, et al. Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-pyrazinyl-1,2,5,6-tetrahydro-1-methylpyridines. Construction of a molecular model for the M1 pharmacophore. J Med Chem. 1992;35(22):4011-4019. Sheardown MJ, et al. M1 receptor agonist activity is not a requirement for muscarinic antinociception. J Pharmacol Exp Ther. 1997;281(2):868-875.